Severe hypertriglyceridemia and pancreatitis: Presentation and management

Current Opinion in Lipidology

Volumn 20, Issue 6, 2009, Pages 497-504

  Ewald, Nils ^a   Hardt, Philip D ^a   Kloer, Hans Ulrich ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Apheresis; Chronic pancreatitis; Hyperlipidemia; Hypertriglyceridemia; Pancreatitis

Indexed keywords

ANALGESIC AGENT; ANTILIPEMIC AGENT; DOCOSAHEXAENOIC ACID; FATTY ACID; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; INSULIN; LIPOPROTEIN; LONG CHAIN FATTY ACID; MEDIUM CHAIN TRIACYLGLYCEROL; NICOTINIC ACID; NICOTINIC ACID DERIVATIVE; OMEGA 3 FATTY ACID; PLACEBO; PROSTAGLANDIN D2 DERIVATIVE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; APHERESIS; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DIAGNOSTIC TEST; DIET THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; EPIDEMIOLOGICAL DATA; FAT TOLERANCE TEST; FLUID THERAPY; GENETIC DISORDER; HOT FLUSH; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIFESTYLE MODIFICATION; LIPOPROTEIN METABOLISM; LONG TERM CARE; MEDICAL EXAMINATION; MYOPATHY; MYOSITIS; OBESITY; OUTCOME ASSESSMENT; PANCREATITIS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

FATTY ACIDS; HUMANS; HYDROLYSIS; HYPERTRIGLYCERIDEMIA; LIPASE; LIPOPROTEINS; PANCREATITIS; TRIGLYCERIDES;

EID: 72649093760     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283319a1d     Document Type: Review

References (77)

1. Fortson MR, Freedman SN, Webster PD III. Clinical assessment of hyperlipi-demic pancreatitis. Am J Gastroenterol 1995; 90:2134-2139.
2. Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am 1990; 19:783-791
3. Speck L A case of lipidemia. Arch Verin Wissenschaftl Heilkunde 1865; 1:232.
4. Anderson F, Thomson SR, Clarke DL, Buccimazza I. Dyslipidaemic pancreatitis clinical assessment and analysis of disease severity and outcomes. Pancreatology 2009; 9:252-257.
5. Chang CC, Hsieh YY, Tsai HD, et al. Acute pancreatitis in pregnancy. Zhonghua Yi Xue Za Zhi 1998; 61:85-92.
6. Fredrickson DS. An international classification of hyperlipidemias and hyperlipoproteinemias. Ann Intern Med 1971; 75:471-472.
7. Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol 2003; 36:54-62.
8. Nair S, Yadav D, Pitchumoni CS. Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKA. Am J Gastroenterol 2000; 95:2795-2800.
9. Havel RJ. Pathogenesis, differentiation and management of hypertriglyceridemia. Adv Intern Med 1969; 15:117-145.
10. Saharia P, Margolis S, Zuidema MD, et al. Acute pancreatitis with hyperlipi-demia: studies with an isolated perfused canine pancreas. Surgery 1977; 82:60-67.
11. Kimura W, Mossner J. Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats. Int J Pancreatol 1996; 20:177-184.
12. Chang YT, Chang MC, Su TC, et al. Association of cystic fibrosis transmem-brane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis. Clin Chem 2008; 54:131-138.
13. Cameron JL, Capuzzi DM, Zuidema GD, et al. Acute pancreatitis with hyperlipiemia: the incidence of lipid abnormalities in acute pancreatitis. Ann Surg 1973; 177:493-499.
14. Dominguez-Munoz JE, Malfertheiner P, Ditschuneit HH, et al. Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. Int J Pancreatol 1991; 10:261-267.
15. Sekimoto M, Takada T, Kawarada Y, et al. JPN Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. J Hepatobiliary Pancreat Surg 2006; 13:10-24.
16. Dominguez-Munoz JE, Junemann F, Malfertheiner P. Hyperlipidemia in acute pancreatitis. Cause or epiphenomenon? Int J Pancreatol 1995; 18:101-106.
17. Guzman S, Nervi F, Llanos O, et al. Impaired lipid clearance in patients with previous acute pancreatitis. Gut 1985; 26:888-889.
18. Haber PS, Wilson JS, Apte MV, et al. Lipid intolerance does not account for susceptibility to alcohol and gallstone pancreatitis. Gastroenterology 1994; 106:742-748.
19. Durrington PN, Twentyman OP, Braganza JM, et al. HTG and laboratory abnormalities of triglyceride catabolism persisting after pancreatitis. Int J Pancreatol 1986; 1:195-203.
20. Lloret Linares C, Pelletier AL, Czernichow S, et al. Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia. Pancreas 2008; 37:13-22.
21. Hofbauer B, Friess H, Weber A, et al. Hyperlipaemia intensifies the course of acute oedematous and acute necrotising pancreatitis in the rat. Gut 1996; 38:753-758.
22. Wang YJ, Sun JB, Li F, Zhang SW. Hyperlipidemia intensifies cerulein-induced acute pancreatitis associated with activation of protein kinase C in rats. World J Gastroenterol 2006; 12:2908-2913.
23. Czako L, Szabolcs A, Vajda A, et al. Hyperlipidemia induced by a cholesterol-rich diet aggravates necrotizing pancreatitis in rats. Eur J Pharmacol 2007; 572:74-81.
24. Warshaw AL, Lesser PB, Rie M, et al. The pathogenesis of pulmonary edema in acute pancreatitis. Ann Surg 1975; 182:505-510.
25. KimuraT, Toung JK, Margolis S, et al. Respiratoryfailure in acute pancreatitis. A possible role for triglycerides. Ann Surg 1979; 189:509-514.
26. BalachandraS, Virlos IT, King NK, et al. Hyperlipidaemiaand outcome in acute pancreatitis. Int J Clin Pract 2006; 60:156-159.
27. Deng LH, Xue P, Xia Q, Yang XN, et al. Effect of admission hypertriglyceridemia on the episodes of severe acute pancreatitis. World J Gastroenterol 2008; 14:4558-4561.
28. Bolan C, Oral EA, Gorden P, et al. Intensive, long-term plasma exchange therapy for severe hypertriglyceridemia in acquired generalized lipoatrophy. J Clin Endocrinol Metab 2002; 87:380-384.
29. Iskandar SB, Olive KE. Plasmapheresis as an adjuvant therapy for hyper-triglyceridemia-induced pancreatitis. Am J Med Sci 2004; 328:290-294.
30. Kyriakidis AV, Karydakis P, Neofytou N, et al. Plasmapheresis in the management of acute severe hyperlipidemic pancreatitis: report of 5 cases. Pan-creatology 2005; 5:201-204.
31. Kyriakidis AV, Raitsiou B, Sakagianni A, et al. Management of acute severe hyperlipidemic pancreatitis. Digestion 2006; 73:259-264.
32. Yeh JH, Chen HJ, Chiu HC. Plasmapheresis for hyperlipidemic pancreatitis. J Clin Apher 2003; 18:181-185.
33. Kadikoylu G, Yavasoglu I, Bolaman Z. Plasma exchange in severe hypertriglyceridemia a clinical study. Transfus Apher Sci 2006; 34:253-257.
34. FuruyaT, Komatsu M, Takahashi K, et al. Plasma exchange for hypertriglyceri-demic acute necrotizing pancreatitis: report of two cases. Ther Apher 2002; 6:454-458.
35. Jabbar MA, Zuhri-Yag MI, Larrea J. Insulin therapy for a nondiabetic patient with severe hypertriglyceridemia. J Am Coll Nutr 1998; 17:458-461.
36. Sleth JC, Lafforgue E, Servais R, et al. A case of hypertriglycideremia- induced pancreatitis in pregnancy: value of heparin. Ann Fr Anesth Reanim 2004; 23:835-837.
37. Mikhail N, Trivedi K, Page C, et al. Treatment of severe hypertriglyceridemia in nondiabetic patients with insulin. Am J Emerg Med 2005; 23:415-417.
38. Tamez-Perez HE, Saenz-Gallegos R, Hernandez-Rodriguez K, et al. Insulin therapy in patients with severe hypertriglyceridemia. Rev Med Inst Mex Seguro Soc 2006; 44:235-237.
39. Henzen C, Rock M, Schnieper C, et al. Heparin and insulin in the treatment of acute hypertriglyceridemia-induced pancreatitis. Schweiz Med Wochenschr 1999; 129:1242-1248.
40. Berger Z, Quera R, Poniachik J, et al. Heparin and insulin treatment of acute pancreatitis caused by hypertriglyceridemia. Experience of 5 cases. Rev Med Chil 2001; 129:1373-1378.
41. Alagozlu H, Mehmet C, Karakan T, et al. Heparin and insulin in the treatment of hypertriglyceridemia-induced severe acute pancreatitis. Dig Dis Sci 2006; 51:931-933.
42. Jain P, Rai RR, Udawat H, et al. Insulin and heparin in treatment of hypertriglyceridemia-induced pancreatitis. World J Gastroenterol 2007; 13:2642-2643.
43. Watts GF, Cameron J, Henderson A, et al. Lipoprotein lipase deficiency due to long-term heparinization presenting as severe hypertriglyceridaemia in pregnancy. Postgrad Med J 1991; 67:1062-1064.
44. Weintraub M, Rassin T, Eisenberg S, et al. Continuous intravenous heparin administration in humans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation. J Lipid Res 1994; 35:29-38.
45. Nasstrom B, Olivecrona G, Olivecrona T, et al. Lipoprotein lipase during continuous heparin infusion: tissue stores become partially depleted. J Lab Clin Med 2001; 138:206-213.
46. Nasstrom B, Stegmayr BG, Olivecrona G, et al. Lower plasma levels of lipoprotein lipase after infusion of low molecular weight heparin than after administration of conventional heparin indicate more rapid catabolism of the enzyme. J Lab Clin Med 2003; 142:90-99.
47. Nasstrom B, Stegmayr B, Gupta J, et al. A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing. Nephrol Dial Transplant 2005; 20:1172-1179.
48. Staels B, Dallongeville J, Auwerx J, et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998; 98:2088-2093.
49. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-3421.
50. McKenney JM, Sica D. Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia. Am J Health Syst Pharm 2007; 64:595-605. (Pubitemid 46481860)
51. Harris WS, Ginsberg HN, Arunakul N, et al. Safety and efficiency of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk 1997; 4:385-391.
52. Khan S, Minihane AM, Talmud PJ, et al. Dietary long-chain n-3 PUFAs increase LPL gene expression in adipose tissue of subjects with an atherogenic lipoprotein phenotype. J Lipid Res 2002; 43:979-985.
53. Wise A, Foord SM, Fraser NJ, et al. Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 2003; 278:9869-9874.
54. Tunaru S, Kero J, Schaub A, et al. PUMA-G and HM74 are receptors for nicotinic acid and mediate its antilipolytic effect. Nat Med 2003; 9:352-355.
55. Karpe F, Frayn KN. The nicotinic acid receptor: a new mechanism for an old drug. Lancet 2004; 363:1892-1894.
56. Athyros VG, Papageorgiou AA, Hatzikonstandinou HA, et al. Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia. Am J Cardiol 1997; 80:608-613.
57. Jones PH, Davidson MH. Reporting rate of rhabdomyolysis with fenofibrate plus statin versus gemfibrozil plus any statin. Am J Cardiol 2005; 95:120-122.
58. Davidson MH, Armani A, McKenney JM, et al. Safety considerations with fibrate therapy. Am J Cardiol 2007; 99:3C-18C.
59. McClure DL, Valuck RJ, Glanz M, et al. Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population. J Clin Epidemiol 2007; 60:812-818.
60. Mizushima T, Ochi K, Matsumura N, et al. Prevention of hyperlipidemic acute pancreatitis during pregnancy with medium-chain triglyceride nutritional support. Int J Pancreatol 1998; 23:187-192.
61. Chen JH, Yeh JH, Lai HW, et al. Therapeutic plasma exchange in patients with hyperlipidemic pancreatitis. World J Gastroenterol 2004; 10:2272-2274.
62. Yeh JH, Lee MF, Chiu HC. Plasmapheresis for severe lipemia: comparison of serum-lipid clearance rates for the plasma-exchange and double-G filtration variants. J Clin Apher 2003; 18:32-36.
63. Benyo Z, Gille A, Kero J, et al. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest 2005; 115:3634-3640.
64. Cheng K, WuTJ, Wu KK, et al. Antagonism of the prostaglandin D-2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. Proc Natl Acad Sci USA 2006; 103:6682-6687.
65. Athyros VG,Giouleme OI, Nikolaidis NL, et al. Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis. J Clin Gastroenterol 2002; 34:472-475.
66. Piolot A, Nadler F, Cavallero E, et al. Prevention of recurrent acute pancreatitis in patients with severe hypertriglyceridemia: value of regular plasmapheresis. Pancreas 1996; 13:96-99.
67. Hauenschild A, Ewald N, Schnell-Kretschmer H, et al. Successful long-term treatment of severe hypertriglyceridemia by feedback control with lipid self-monitoring. Ann Nutr Metab 2008; 52:215-220.
68. Stroes ES, Nierman MC, Meulenberg JJ, et al. Intramuscular administra-tion of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients. Arterioscler Thromb Vasc Biol 2008; 28:2303-2304.
69. Krauss RM, Levy AG. Subclinical chronic pancreatitis in type I hyperlipopro-teinemia. Am J Med 1977; 62:144-149.
70. Hacken JB, Moccia RM. Calcific pancreatitis in a patient with type 5 hyperli-poproteinemia. Gastrointestinal Radiol 1979; 4:143-146.
71. Einarsson K, Hellstrom K, Kallner M. Gallbladder disease in hyperlipoprotei-naemia. Lancet 1975; 1:484-487.
72. Ahlberg J, Angelin B, Einarsson K, et al. Prevalence of gallbladder disease in hyperlipoproteinemia. Dig Dis Sci 1979; 24:459-464.
73. Tîrziu S, Bel S, Bondor CI, Acalovschi M. Risk factors for gallstone disease in patients with gallstones having gallstone heredity. A case-control study. Rom J Intern Med 2008; 46:223-228.
74. Bernhard JP, Laugier R. The pathogenesis of chronic pancreatitis. In: Johnson CD, Imrie CW, editors. Pancreatic disease: progress and prospects. Berlin: Springer Verlag; 1991. pp. 185-193.
75. Tamasky PR, Hoffmann B, Aabakken L, et al. Sphincter of oddi dysfunction is associated with chronic pancreatitis. Am J Gastroenterol 1997; 7:1125-1129.
76. Ros E, Navarro S, Bru C, et al. Occult microlithiasis in idiopathic acute pancreatitis: prevention of relapses by cholecystectomy or ursodesoxycholic acid therapy. Gastroenterology 1991; 101:1701-1709.
77. Tsuang W, Navaneethan U, Ruiz L, et al. Hypertriglyceridemic pancreatitis: presentation and management. Am J Gastroenterol 2009; 104:984-991.